Protein Kinase Inhibitors: all 15,766 studies that test it
Page 138 of 158. Open to participants first (2,605), then studies with results posted, then the rest; newest registration first within each.
- Study of NMS-1116354 in Advanced/Metastatic Solid TumorsTerminatedNCT01092052Phase 1
- Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)Status unknownNCT01091376Phase 2
- Sorafenib for Imatinib/Sunitinib-failed GISTCompletedNCT01091207Phase 2
- A Study Evaluating the Safety and Tolerability of GDC-0068 in Patients With Refractory Solid TumorsCompletedNCT01090960Phase 1
- Safety, Pharmacokinetic (PK), Pharmcodynamic (PD), and Drug-Drug Interaction of PLX3397 in Patients With Rheumatoid Arthritis Who Are Receiving MethotrexateWithdrawnNCT01090570Phase 1
- Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the UrotheliumCompletedNCT01090466Phase 1/2
- Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade GliomaActive, not recruitingNCT01089101Phase 1/2
- Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)CompletedNCT01089088Phase 2
- Everolimus in Breast Cancer Patients After Pre-operative ChemotherapyStatus unknownNCT01088893Phase 2
- Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing CholangitisCompletedNCT01088607Phase 1
- Lapatinib With Sirolimus or MetforminCompletedNCT01087983Phase 1
- Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced CancerActive, not recruitingNCT01087554Phase 1
- Erlotinib in Higher Risk Myelodysplastic SyndromeCompletedNCT01085838Phase 1/2
- Standard Chemotherapy with or Without Nelarabine or Rituximab in Treating Patients with Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT01085617
- Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01083589Phase 2
- Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast CancerCompletedNCT01082068Phase 1/2
- A Phase I, Dose-escalation Study of AS703569 Given Orally to Subjects With Haematological MalignanciesTerminatedNCT01080664Phase 1
- Study Comparing Two Different Tablet Formulations Of Bosutinib Under Fed ConditionsCompletedNCT01080365Phase 1
- Temsirolimus in Treating Patients With Advanced Liver Cancer and CirrhosisTerminatedNCT01079767Phase 2
- Everolimus and Capecitabine in Patients With Advanced MalignancyStatus unknownNCT01079702Phase 1/2
- Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung CancerCompletedNCT01079481Phase 1
- Study of Nelfinavir and Temsirolimus in Patients With Advanced CancersCompletedNCT01079286Phase 1
- An Expanded Cohort Trial of Bortezomib and Sorafenib in Advanced Malignant MelanomaCompletedNCT01078961Phase 1
- Temsirolimus, Bendamustine and Rituximab for Relapsed Follicular Lymphoma or Mantle Cell LymphomaCompletedNCT01078142Phase 1/2
- Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic CancerCompletedNCT01077986Phase 1/2
- Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaTerminatedNCT01076556Phase 1
- Study of Tamoxifen Dose Escalation in Breast Cancer Patients With CYP2D6 PolymorphismsCompletedNCT01075802Not applicable
- Sorafenib and Vorinostat in Treating Patients With Advanced Liver CancerCompletedNCT01075113Phase 1
- Safety and Efficacy Study of KX2-391 for Treatment of Bone-Metastatic, Castration-Resistant Prostate CancerCompletedNCT01074138Phase 2
- Phase I Study in RAD 001 Patients With Relapse AMLCompletedNCT01074086Phase 1
- Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver TransplantationCompletedNCT01073202Not applicable
- Temsirolimus and Pazopanib in Patients With Advanced Solid TumorsCompletedNCT01072890Phase 1
- A Dose-escalation Study in Subjects With Advanced MalignanciesCompletedNCT01072266Phase 1
- A Safety Study to Evaluate Pazopanib Eye Drops in Healthy VolunteersCompletedNCT01072214Phase 1
- Effect of Ridaforolimus on the Pharmacokinetics of Midazolam (Study MK-8669-044)CompletedNCT01071304Phase 1
- A Study of MK2206 in Locally Advanced or Metastatic Solid Tumors (2206-007)CompletedNCT01071018Phase 1
- Phase Ib/II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and SunitinibCompletedNCT01070706Phase 1/2
- A Study of ARQ 197 Versus Investigator's Choice of Second-Line Chemotherapy in Patients With Locally Advanced or Metastatic Gastric Cancer Who Have Progressive Neoplastic Disease Following Treatment With One Prior Chemotherapy RegimenWithdrawnNCT01070290Phase 2
- Study of Sunitinib in Subjects With High Risk Renal Cell CarcinomaWithdrawnNCT01070186Phase 2
- Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC)Status unknownNCT01069770Phase 2
- A Study of ARQ 197 in Combination With ErlotinibCompletedNCT01069757Phase 1
- Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC)CompletedNCT01069328Phase 1
- Efficacy and Safety of BMS-690514 in Combination With Letrozole to Treat Metastatic Breast CancerCompletedNCT01068704Phase 2
- Safety of BKM120 Monotherapy in Advanced Solid Tumor PatientsCompletedNCT01068483Phase 1
- A Study of First or Second Line Treatment With Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT01066884Phase 4
- Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders.TerminatedNCT01066468Phase 1
- Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyStatus unknownNCT01066195Phase 3
- AZD2171 and Temsirolimus in Patients With Advanced Gynecological MalignanciesCompletedNCT01065662Phase 1
- Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLCTerminatedNCT01063478Phase 1
- A Dose Escalating Clinical Trial of the IGF-1 Receptor Inhibitor AXL1717 in Patients With Advanced CancerCompletedNCT01062620Phase 1
- A Trial of AMG 479, Everolimus (RAD001) and Panitumumab in Patients With Advanced Cancer - QUILT-3.007CompletedNCT01061788Phase 1
- Selumetinib and Cixutumumab in Treating Patients With Advanced Solid MalignanciesCompletedNCT01061749Phase 1
- Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by SurgeryCompletedNCT01061411Phase 1
- Pre Transplant Rapamycin Treatment in Islet Transplantation AloneCompletedNCT01060605Phase 3
- Study of AR-12286 Versus Latanoprost in Patients With Elevated Intraocular PressureCompletedNCT01060579Phase 2
- Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast CancerTerminatedNCT01060514Phase 1
- Phase II Pazopanib Study in Advanced DermatofibrosarcomasTerminatedNCT01059656Phase 2
- Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal TranslocationCompletedNCT01058434Phase 2
- RAD001 With Weekly Cisplatin and Radiation Therapy in Patients With Locally Advanced Head and Neck CancerTerminatedNCT01058408Phase 1
- Safety Study of Bevacizumab, Everolimus and LBH589 (BEL) for Advanced Solid TumorsCompletedNCT01055795Phase 1
- Single Dose Study With 4SC-203 in Healthy VolunteersCompletedNCT01054937Phase 1
- Docetaxel and Sirolimus in Patients With Advanced MalignanciesCompletedNCT01054313Phase 1
- A Single and Multiple Dose Study to Explore the Safety Of JNJ-40346527 In Healthy VolunteersCompletedNCT01054014Phase 1
- Curcumin for Type 2 Diabetic PatientsStatus unknownNCT01052597Phase 4
- A 12-week Study of 4 Doses of VX-509 in Subjects With Active Rheumatoid ArthritisCompletedNCT01052194Phase 2
- Curcumin Therapy in Patients With Impaired Glucose Tolerance and Insulin ResistanceStatus unknownNCT01052025Phase 4
- A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in HumansCompletedNCT01051700Phase 1
- Dasatinib Combination for Chronic Lymphocytic Leukemia(CLL) With Refractory DiseaseStatus unknownNCT01051115Phase 2
- A Study of Temsirolimus Plus Capecitabine in Patients With Advanced CancerCompletedNCT01050985Phase 1
- Perifosine With Temsirolimus for Recurrent Pediatric Solid TumorsCompletedNCT01049841Phase 1
- RAD001 in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer: RAD001+XELOXCompletedNCT01049620Phase 1
- Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)WithdrawnNCT01048983Phase 1/2
- Safety and Pharmacokinetic Study of Oral ON 01910.Na in Patients With Myelodysplastic SyndromeCompletedNCT01048619Phase 1
- Study of Perifosine + Capecitabine for Colon Cancer PatientsCompletedNCT01048580Phase 1
- Gemcitabine and Oxaliplatin (Gem-Ox) Plus Glivec in Gemcitabine-refractory Pancreatic CancerCompletedNCT01048320Phase 1
- Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian CancerCompletedNCT01047891Phase 2
- Everolimus Rescue Immunosuppression in the Treatment of Chronic Allograft Dysfunction in Renal Transplant RecipientsCompletedNCT01046045Phase 4
- A Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Activity of Oral AB1010 in Adults Patients With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT01045577Phase 2
- Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast CancerCompletedNCT01044485Phase 1/2
- Ridaforolimus in Patients With Hepatic Insufficiency (MK-8669-046)CompletedNCT01043887Phase 1
- Phase I Study of Daily RAD001 in Combination With Mitomycin C in Patients With Advanced Gastric Cancer or Cancer of the Esophagogastric JunctionCompletedNCT01042782Phase 1
- Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver CancerCompletedNCT01042041Phase 1
- A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic CancerTerminatedNCT01042028Phase 1/2
- A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell CarcinomaStatus unknownNCT01041482Phase 2
- PK Study of IV Formulation of GW856553CompletedNCT01039961Phase 1
- A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung CancerCompletedNCT01039948Phase 1/2
- Comparison of Tacrolimus and Myfortic Versus Tacrolimus and SirolimusWithdrawnNCT01038505Phase 4
- UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung CancerCompletedNCT01037998Phase 2
- Trial on Safety and Pharmacokinetics of Intravaginal CurcuminCompletedNCT01035580Phase 1
- Sunitinib in Metastatic Renal CancerCompletedNCT01034878Phase 2
- Effect of Rapamycin on Tolerance-related Biomarkers on Stable Liver Transplant RecipientsStatus unknownNCT01034345Phase 2
- Phase I Study of Palomid 529 a Dual TORC1/2 Inhibitor of the PI3K/Akt/mTOR Pathway for Advanced Neovascular Age-Related Macular DegenerationCompletedNCT01033721Phase 1
- Pazopanib Hydrochloride in Treating Patients With Metastatic Urethral Cancer or Bladder Cancer That Has Relapsed or Not Responded to TreatmentCompletedNCT01031875Phase 2
- Bioavailability and Food Effect Study of TKI258 (CSF Capsules vs. FMI Capsules)in Adult Patients With Advanced Solid TumorsCompletedNCT01030055Phase 1
- AZD6244 and Sorafenib in Advanced Hepatocellular CarcinomaTerminatedNCT01029418Phase 1/2
- mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal TransplantationCompletedNCT01028092Phase 3
- A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic CancerTerminatedNCT01025570Phase 1
- Ph+/Bcr-Abl+ ALL Imatinib and Nilotinib Rotational StudyCompletedNCT01025505Phase 2
- Paclitaxel, Carboplatin, and Gefitinib in Treating Patients With Advanced Non-Small Cell Lung CancerStatus unknownNCT01024712Phase 2
- Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 MutationsCompletedNCT01024413Phase 3